For citations:
Eliseev M.S., Zhelyabin O.V., Barskova V.G., Nasonov E.L. EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT. Rheumatology Science and Practice. 2014;52(1):99-101. (In Russ.) https://doi.org/10.14412/1995-4484-2014-99-101